nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Pemetrexed—lung cancer	0.267	0.765	CrCtD
Pralatrexate—TYMS—lung cancer	0.128	1	CbGaD
Pralatrexate—Methotrexate—lung cancer	0.0822	0.235	CrCtD
Pralatrexate—DHFR—Pemetrexed—lung cancer	0.0732	0.33	CbGbCtD
Pralatrexate—TYMS—Pemetrexed—lung cancer	0.051	0.23	CbGbCtD
Pralatrexate—Tetrahydrofolic acid—Pemetrexed—lung cancer	0.0355	0.153	CrCrCtD
Pralatrexate—Methotrexate—Pemetrexed—lung cancer	0.0355	0.153	CrCrCtD
Pralatrexate—Folic Acid—Pemetrexed—lung cancer	0.0355	0.153	CrCrCtD
Pralatrexate—Leucovorin—Pemetrexed—lung cancer	0.0355	0.153	CrCrCtD
Pralatrexate—Raltitrexed—Pemetrexed—lung cancer	0.0355	0.153	CrCrCtD
Pralatrexate—SLC19A1—Methotrexate—lung cancer	0.0339	0.153	CbGbCtD
Pralatrexate—FPGS—Methotrexate—lung cancer	0.0245	0.11	CbGbCtD
Pralatrexate—TYMS—Gemcitabine—lung cancer	0.0184	0.0827	CbGbCtD
Pralatrexate—DHFR—Methotrexate—lung cancer	0.0124	0.056	CbGbCtD
Pralatrexate—Pemetrexed—Methotrexate—lung cancer	0.0109	0.0471	CrCrCtD
Pralatrexate—Raltitrexed—Methotrexate—lung cancer	0.0109	0.0471	CrCrCtD
Pralatrexate—Leucovorin—Methotrexate—lung cancer	0.0109	0.0471	CrCrCtD
Pralatrexate—Folic Acid—Methotrexate—lung cancer	0.0109	0.0471	CrCrCtD
Pralatrexate—Tetrahydrofolic acid—Methotrexate—lung cancer	0.0109	0.0471	CrCrCtD
Pralatrexate—TYMS—Methotrexate—lung cancer	0.00866	0.039	CbGbCtD
Pralatrexate—SLC19A1—mammary gland—lung cancer	0.00186	0.173	CbGeAlD
Pralatrexate—FPGS—respiratory system—lung cancer	0.000826	0.077	CbGeAlD
Pralatrexate—FPGS—bronchus—lung cancer	0.00068	0.0634	CbGeAlD
Pralatrexate—SLC19A1—lung—lung cancer	0.000658	0.0614	CbGeAlD
Pralatrexate—FPGS—trachea—lung cancer	0.000611	0.0569	CbGeAlD
Pralatrexate—FPGS—cardiac atrium—lung cancer	0.000574	0.0535	CbGeAlD
Pralatrexate—TYMS—respiratory system—lung cancer	0.000542	0.0505	CbGeAlD
Pralatrexate—DHFR—respiratory system—lung cancer	0.000537	0.05	CbGeAlD
Pralatrexate—SLC19A1—lymph node—lung cancer	0.00045	0.042	CbGeAlD
Pralatrexate—TYMS—bronchus—lung cancer	0.000446	0.0416	CbGeAlD
Pralatrexate—DHFR—bronchus—lung cancer	0.000442	0.0412	CbGeAlD
Pralatrexate—FPGS—lung—lung cancer	0.000439	0.0409	CbGeAlD
Pralatrexate—DHFR—trachea—lung cancer	0.000397	0.037	CbGeAlD
Pralatrexate—DHFR—cardiac atrium—lung cancer	0.000372	0.0347	CbGeAlD
Pralatrexate—TYMS—bone marrow—lung cancer	0.000318	0.0296	CbGeAlD
Pralatrexate—DHFR—bone marrow—lung cancer	0.000314	0.0293	CbGeAlD
Pralatrexate—FPGS—lymph node—lung cancer	0.0003	0.028	CbGeAlD
Pralatrexate—TYMS—lung—lung cancer	0.000288	0.0268	CbGeAlD
Pralatrexate—DHFR—lung—lung cancer	0.000285	0.0266	CbGeAlD
Pralatrexate—Raltitrexed—TYMS—lung cancer	0.000263	0.179	CrCbGaD
Pralatrexate—Leucovorin—ABCC3—lung cancer	0.00025	0.17	CrCbGaD
Pralatrexate—TYMS—Docetaxel—Paclitaxel—lung cancer	0.0002	0.185	CbGdCrCtD
Pralatrexate—Leucovorin—TYMS—lung cancer	0.000199	0.136	CrCbGaD
Pralatrexate—TYMS—lymph node—lung cancer	0.000197	0.0183	CbGeAlD
Pralatrexate—DHFR—lymph node—lung cancer	0.000195	0.0182	CbGeAlD
Pralatrexate—Folic Acid—ABCC3—lung cancer	0.000161	0.11	CrCbGaD
Pralatrexate—Pemetrexed—TYMS—lung cancer	0.000159	0.108	CrCbGaD
Pralatrexate—TYMS—Erlotinib—Gefitinib—lung cancer	0.00015	0.138	CbGdCrCtD
Pralatrexate—Methotrexate—ABCC3—lung cancer	0.00011	0.0749	CrCbGaD
Pralatrexate—TYMS—Podofilox—Teniposide—lung cancer	0.000108	0.0995	CbGdCrCtD
Pralatrexate—TYMS—Paclitaxel—Docetaxel—lung cancer	0.0001	0.0922	CbGdCrCtD
Pralatrexate—TYMS—Afatinib—Gefitinib—lung cancer	9.79e-05	0.0902	CbGdCrCtD
Pralatrexate—TYMS—Gefitinib—Erlotinib—lung cancer	9.6e-05	0.0884	CbGdCrCtD
Pralatrexate—Methotrexate—TYMS—lung cancer	8.79e-05	0.0598	CrCbGaD
Pralatrexate—Folic Acid—ABCG2—lung cancer	7.82e-05	0.0532	CrCbGaD
Pralatrexate—Pancytopenia—Paclitaxel—lung cancer	7.59e-05	0.00237	CcSEcCtD
Pralatrexate—Pruritus—Teniposide—lung cancer	7.54e-05	0.00236	CcSEcCtD
Pralatrexate—Anorexia—Topotecan—lung cancer	7.53e-05	0.00235	CcSEcCtD
Pralatrexate—Neutropenia—Paclitaxel—lung cancer	7.48e-05	0.00234	CcSEcCtD
Pralatrexate—Anorexia—Erlotinib—lung cancer	7.45e-05	0.00233	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Paclitaxel—lung cancer	7.43e-05	0.00232	CcSEcCtD
Pralatrexate—Leukopenia—Vinorelbine—lung cancer	7.41e-05	0.00232	CcSEcCtD
Pralatrexate—Diarrhoea—Teniposide—lung cancer	7.29e-05	0.00228	CcSEcCtD
Pralatrexate—Dehydration—Docetaxel—lung cancer	7.29e-05	0.00228	CcSEcCtD
Pralatrexate—Liver function test abnormal—Docetaxel—lung cancer	7.24e-05	0.00226	CcSEcCtD
Pralatrexate—Cough—Vinorelbine—lung cancer	7.23e-05	0.00226	CcSEcCtD
Pralatrexate—Decreased appetite—Vinblastine—lung cancer	7.07e-05	0.00221	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Docetaxel—lung cancer	7.06e-05	0.00221	CcSEcCtD
Pralatrexate—Dyspnoea—Topotecan—lung cancer	7.04e-05	0.0022	CcSEcCtD
Pralatrexate—Dyspnoea—Erlotinib—lung cancer	6.97e-05	0.00218	CcSEcCtD
Pralatrexate—Constipation—Vinblastine—lung cancer	6.96e-05	0.00217	CcSEcCtD
Pralatrexate—TYMS—Vincristine—Vinorelbine—lung cancer	6.88e-05	0.0633	CbGdCrCtD
Pralatrexate—Decreased appetite—Topotecan—lung cancer	6.87e-05	0.00215	CcSEcCtD
Pralatrexate—Fatigue—Topotecan—lung cancer	6.81e-05	0.00213	CcSEcCtD
Pralatrexate—Decreased appetite—Erlotinib—lung cancer	6.8e-05	0.00212	CcSEcCtD
Pralatrexate—Vomiting—Teniposide—lung cancer	6.78e-05	0.00212	CcSEcCtD
Pralatrexate—Constipation—Topotecan—lung cancer	6.76e-05	0.00211	CcSEcCtD
Pralatrexate—Sepsis—Methotrexate—lung cancer	6.76e-05	0.00211	CcSEcCtD
Pralatrexate—Fatigue—Erlotinib—lung cancer	6.74e-05	0.00211	CcSEcCtD
Pralatrexate—Epistaxis—Paclitaxel—lung cancer	6.72e-05	0.0021	CcSEcCtD
Pralatrexate—Rash—Teniposide—lung cancer	6.72e-05	0.0021	CcSEcCtD
Pralatrexate—Dermatitis—Teniposide—lung cancer	6.72e-05	0.0021	CcSEcCtD
Pralatrexate—Constipation—Erlotinib—lung cancer	6.68e-05	0.00209	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Vinblastine—lung cancer	6.65e-05	0.00208	CcSEcCtD
Pralatrexate—Thrombocytopenia—Vinorelbine—lung cancer	6.62e-05	0.00207	CcSEcCtD
Pralatrexate—Back pain—Irinotecan—lung cancer	6.61e-05	0.00206	CcSEcCtD
Pralatrexate—Tachycardia—Vinorelbine—lung cancer	6.6e-05	0.00206	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Topotecan—lung cancer	6.46e-05	0.00202	CcSEcCtD
Pralatrexate—Anorexia—Vinorelbine—lung cancer	6.44e-05	0.00201	CcSEcCtD
Pralatrexate—Back pain—Gemcitabine—lung cancer	6.44e-05	0.00201	CcSEcCtD
Pralatrexate—Pancytopenia—Docetaxel—lung cancer	6.44e-05	0.00201	CcSEcCtD
Pralatrexate—Abdominal pain—Vinblastine—lung cancer	6.43e-05	0.00201	CcSEcCtD
Pralatrexate—TYMS—Vinorelbine—Vinblastine—lung cancer	6.43e-05	0.0592	CbGdCrCtD
Pralatrexate—TYMS—Podofilox—Etoposide—lung cancer	6.42e-05	0.0592	CbGdCrCtD
Pralatrexate—Gastrointestinal pain—Erlotinib—lung cancer	6.39e-05	0.002	CcSEcCtD
Pralatrexate—Neutropenia—Docetaxel—lung cancer	6.34e-05	0.00198	CcSEcCtD
Pralatrexate—Nausea—Teniposide—lung cancer	6.33e-05	0.00198	CcSEcCtD
Pralatrexate—Anaemia—Irinotecan—lung cancer	6.31e-05	0.00197	CcSEcCtD
Pralatrexate—Abdominal pain—Topotecan—lung cancer	6.25e-05	0.00195	CcSEcCtD
Pralatrexate—Body temperature increased—Topotecan—lung cancer	6.25e-05	0.00195	CcSEcCtD
Pralatrexate—Folic Acid—CYP2E1—lung cancer	6.21e-05	0.0422	CrCbGaD
Pralatrexate—Body temperature increased—Erlotinib—lung cancer	6.18e-05	0.00193	CcSEcCtD
Pralatrexate—Abdominal pain—Erlotinib—lung cancer	6.18e-05	0.00193	CcSEcCtD
Pralatrexate—Anaemia—Gemcitabine—lung cancer	6.15e-05	0.00192	CcSEcCtD
Pralatrexate—Leukopenia—Irinotecan—lung cancer	6.11e-05	0.00191	CcSEcCtD
Pralatrexate—Dyspnoea—Vinorelbine—lung cancer	6.03e-05	0.00188	CcSEcCtD
Pralatrexate—Cough—Irinotecan—lung cancer	5.96e-05	0.00186	CcSEcCtD
Pralatrexate—Leukopenia—Gemcitabine—lung cancer	5.96e-05	0.00186	CcSEcCtD
Pralatrexate—Decreased appetite—Vinorelbine—lung cancer	5.88e-05	0.00184	CcSEcCtD
Pralatrexate—Sepsis—Doxorubicin—lung cancer	5.85e-05	0.00183	CcSEcCtD
Pralatrexate—Asthenia—Vinblastine—lung cancer	5.84e-05	0.00182	CcSEcCtD
Pralatrexate—Fatigue—Vinorelbine—lung cancer	5.83e-05	0.00182	CcSEcCtD
Pralatrexate—Cough—Gemcitabine—lung cancer	5.81e-05	0.00181	CcSEcCtD
Pralatrexate—Constipation—Vinorelbine—lung cancer	5.78e-05	0.00181	CcSEcCtD
Pralatrexate—Anaemia—Cisplatin—lung cancer	5.73e-05	0.00179	CcSEcCtD
Pralatrexate—Epistaxis—Docetaxel—lung cancer	5.7e-05	0.00178	CcSEcCtD
Pralatrexate—Asthenia—Topotecan—lung cancer	5.67e-05	0.00177	CcSEcCtD
Pralatrexate—Asthenia—Erlotinib—lung cancer	5.61e-05	0.00175	CcSEcCtD
Pralatrexate—Pruritus—Topotecan—lung cancer	5.59e-05	0.00175	CcSEcCtD
Pralatrexate—Oedema—Irinotecan—lung cancer	5.57e-05	0.00174	CcSEcCtD
Pralatrexate—Diarrhoea—Vinblastine—lung cancer	5.56e-05	0.00174	CcSEcCtD
Pralatrexate—Leukopenia—Cisplatin—lung cancer	5.55e-05	0.00173	CcSEcCtD
Pralatrexate—Pruritus—Erlotinib—lung cancer	5.53e-05	0.00173	CcSEcCtD
Pralatrexate—TYMS—Vinblastine—Vinorelbine—lung cancer	5.53e-05	0.0509	CbGdCrCtD
Pralatrexate—Gastrointestinal pain—Vinorelbine—lung cancer	5.53e-05	0.00173	CcSEcCtD
Pralatrexate—TYMS—Vincristine—Vinblastine—lung cancer	5.5e-05	0.0506	CbGdCrCtD
Pralatrexate—Back pain—Etoposide—lung cancer	5.5e-05	0.00172	CcSEcCtD
Pralatrexate—Thrombocytopenia—Irinotecan—lung cancer	5.46e-05	0.00171	CcSEcCtD
Pralatrexate—Oedema—Gemcitabine—lung cancer	5.43e-05	0.0017	CcSEcCtD
Pralatrexate—Diarrhoea—Topotecan—lung cancer	5.41e-05	0.00169	CcSEcCtD
Pralatrexate—Back pain—Paclitaxel—lung cancer	5.39e-05	0.00168	CcSEcCtD
Pralatrexate—Methotrexate—ABCG2—lung cancer	5.35e-05	0.0364	CrCbGaD
Pralatrexate—Diarrhoea—Erlotinib—lung cancer	5.35e-05	0.00167	CcSEcCtD
Pralatrexate—Body temperature increased—Vinorelbine—lung cancer	5.34e-05	0.00167	CcSEcCtD
Pralatrexate—Abdominal pain—Vinorelbine—lung cancer	5.34e-05	0.00167	CcSEcCtD
Pralatrexate—Thrombocytopenia—Gemcitabine—lung cancer	5.32e-05	0.00166	CcSEcCtD
Pralatrexate—Anorexia—Irinotecan—lung cancer	5.31e-05	0.00166	CcSEcCtD
Pralatrexate—Anaemia—Etoposide—lung cancer	5.25e-05	0.00164	CcSEcCtD
Pralatrexate—Liver function test abnormal—Methotrexate—lung cancer	5.22e-05	0.00163	CcSEcCtD
Pralatrexate—Anorexia—Gemcitabine—lung cancer	5.18e-05	0.00162	CcSEcCtD
Pralatrexate—Vomiting—Vinblastine—lung cancer	5.17e-05	0.00162	CcSEcCtD
Pralatrexate—Anaemia—Paclitaxel—lung cancer	5.15e-05	0.00161	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Methotrexate—lung cancer	5.09e-05	0.00159	CcSEcCtD
Pralatrexate—Leukopenia—Etoposide—lung cancer	5.09e-05	0.00159	CcSEcCtD
Pralatrexate—Oedema—Cisplatin—lung cancer	5.06e-05	0.00158	CcSEcCtD
Pralatrexate—Vomiting—Topotecan—lung cancer	5.02e-05	0.00157	CcSEcCtD
Pralatrexate—Leukopenia—Paclitaxel—lung cancer	4.99e-05	0.00156	CcSEcCtD
Pralatrexate—Rash—Topotecan—lung cancer	4.98e-05	0.00156	CcSEcCtD
Pralatrexate—Dermatitis—Topotecan—lung cancer	4.98e-05	0.00155	CcSEcCtD
Pralatrexate—Vomiting—Erlotinib—lung cancer	4.97e-05	0.00155	CcSEcCtD
Pralatrexate—Dyspnoea—Irinotecan—lung cancer	4.97e-05	0.00155	CcSEcCtD
Pralatrexate—Cough—Etoposide—lung cancer	4.96e-05	0.00155	CcSEcCtD
Pralatrexate—Thrombocytopenia—Cisplatin—lung cancer	4.96e-05	0.00155	CcSEcCtD
Pralatrexate—Tachycardia—Cisplatin—lung cancer	4.94e-05	0.00154	CcSEcCtD
Pralatrexate—Rash—Erlotinib—lung cancer	4.93e-05	0.00154	CcSEcCtD
Pralatrexate—Dermatitis—Erlotinib—lung cancer	4.92e-05	0.00154	CcSEcCtD
Pralatrexate—Pain in extremity—Doxorubicin—lung cancer	4.89e-05	0.00153	CcSEcCtD
Pralatrexate—Cough—Paclitaxel—lung cancer	4.86e-05	0.00152	CcSEcCtD
Pralatrexate—Asthenia—Vinorelbine—lung cancer	4.85e-05	0.00151	CcSEcCtD
Pralatrexate—Decreased appetite—Irinotecan—lung cancer	4.85e-05	0.00151	CcSEcCtD
Pralatrexate—Dyspnoea—Gemcitabine—lung cancer	4.84e-05	0.00151	CcSEcCtD
Pralatrexate—Nausea—Vinblastine—lung cancer	4.83e-05	0.00151	CcSEcCtD
Pralatrexate—Anorexia—Cisplatin—lung cancer	4.82e-05	0.00151	CcSEcCtD
Pralatrexate—Fatigue—Irinotecan—lung cancer	4.81e-05	0.0015	CcSEcCtD
Pralatrexate—Pruritus—Vinorelbine—lung cancer	4.78e-05	0.00149	CcSEcCtD
Pralatrexate—Constipation—Irinotecan—lung cancer	4.77e-05	0.00149	CcSEcCtD
Pralatrexate—Decreased appetite—Gemcitabine—lung cancer	4.72e-05	0.00147	CcSEcCtD
Pralatrexate—Nausea—Topotecan—lung cancer	4.69e-05	0.00147	CcSEcCtD
Pralatrexate—Fatigue—Gemcitabine—lung cancer	4.68e-05	0.00146	CcSEcCtD
Pralatrexate—Constipation—Gemcitabine—lung cancer	4.64e-05	0.00145	CcSEcCtD
Pralatrexate—Nausea—Erlotinib—lung cancer	4.64e-05	0.00145	CcSEcCtD
Pralatrexate—Pancytopenia—Methotrexate—lung cancer	4.64e-05	0.00145	CcSEcCtD
Pralatrexate—Diarrhoea—Vinorelbine—lung cancer	4.62e-05	0.00144	CcSEcCtD
Pralatrexate—Back pain—Docetaxel—lung cancer	4.57e-05	0.00143	CcSEcCtD
Pralatrexate—Neutropenia—Methotrexate—lung cancer	4.57e-05	0.00143	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Irinotecan—lung cancer	4.56e-05	0.00142	CcSEcCtD
Pralatrexate—Dehydration—Doxorubicin—lung cancer	4.55e-05	0.00142	CcSEcCtD
Pralatrexate—Oedema—Paclitaxel—lung cancer	4.55e-05	0.00142	CcSEcCtD
Pralatrexate—Thrombocytopenia—Etoposide—lung cancer	4.54e-05	0.00142	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Methotrexate—lung cancer	4.54e-05	0.00142	CcSEcCtD
Pralatrexate—Tachycardia—Etoposide—lung cancer	4.53e-05	0.00141	CcSEcCtD
Pralatrexate—Liver function test abnormal—Doxorubicin—lung cancer	4.52e-05	0.00141	CcSEcCtD
Pralatrexate—Dyspnoea—Cisplatin—lung cancer	4.51e-05	0.00141	CcSEcCtD
Pralatrexate—Hypokalaemia—Doxorubicin—lung cancer	4.45e-05	0.00139	CcSEcCtD
Pralatrexate—Thrombocytopenia—Paclitaxel—lung cancer	4.45e-05	0.00139	CcSEcCtD
Pralatrexate—Tachycardia—Paclitaxel—lung cancer	4.44e-05	0.00139	CcSEcCtD
Pralatrexate—Anorexia—Etoposide—lung cancer	4.42e-05	0.00138	CcSEcCtD
Pralatrexate—Abdominal pain—Irinotecan—lung cancer	4.41e-05	0.00138	CcSEcCtD
Pralatrexate—Body temperature increased—Irinotecan—lung cancer	4.41e-05	0.00138	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Doxorubicin—lung cancer	4.41e-05	0.00138	CcSEcCtD
Pralatrexate—Decreased appetite—Cisplatin—lung cancer	4.4e-05	0.00137	CcSEcCtD
Pralatrexate—Anaemia—Docetaxel—lung cancer	4.36e-05	0.00136	CcSEcCtD
Pralatrexate—Anorexia—Paclitaxel—lung cancer	4.33e-05	0.00135	CcSEcCtD
Pralatrexate—Vomiting—Vinorelbine—lung cancer	4.3e-05	0.00134	CcSEcCtD
Pralatrexate—Body temperature increased—Gemcitabine—lung cancer	4.29e-05	0.00134	CcSEcCtD
Pralatrexate—Rash—Vinorelbine—lung cancer	4.26e-05	0.00133	CcSEcCtD
Pralatrexate—Dermatitis—Vinorelbine—lung cancer	4.26e-05	0.00133	CcSEcCtD
Pralatrexate—Leukopenia—Docetaxel—lung cancer	4.23e-05	0.00132	CcSEcCtD
Pralatrexate—Dyspnoea—Etoposide—lung cancer	4.13e-05	0.00129	CcSEcCtD
Pralatrexate—Cough—Docetaxel—lung cancer	4.12e-05	0.00129	CcSEcCtD
Pralatrexate—Epistaxis—Methotrexate—lung cancer	4.11e-05	0.00128	CcSEcCtD
Pralatrexate—Dyspnoea—Paclitaxel—lung cancer	4.05e-05	0.00127	CcSEcCtD
Pralatrexate—Decreased appetite—Etoposide—lung cancer	4.03e-05	0.00126	CcSEcCtD
Pralatrexate—Pancytopenia—Doxorubicin—lung cancer	4.02e-05	0.00125	CcSEcCtD
Pralatrexate—Nausea—Vinorelbine—lung cancer	4.01e-05	0.00125	CcSEcCtD
Pralatrexate—Body temperature increased—Cisplatin—lung cancer	4e-05	0.00125	CcSEcCtD
Pralatrexate—Asthenia—Irinotecan—lung cancer	4e-05	0.00125	CcSEcCtD
Pralatrexate—Fatigue—Etoposide—lung cancer	4e-05	0.00125	CcSEcCtD
Pralatrexate—Constipation—Etoposide—lung cancer	3.97e-05	0.00124	CcSEcCtD
Pralatrexate—Neutropenia—Doxorubicin—lung cancer	3.95e-05	0.00124	CcSEcCtD
Pralatrexate—Decreased appetite—Paclitaxel—lung cancer	3.95e-05	0.00123	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Doxorubicin—lung cancer	3.93e-05	0.00123	CcSEcCtD
Pralatrexate—Fatigue—Paclitaxel—lung cancer	3.92e-05	0.00122	CcSEcCtD
Pralatrexate—Asthenia—Gemcitabine—lung cancer	3.9e-05	0.00122	CcSEcCtD
Pralatrexate—Constipation—Paclitaxel—lung cancer	3.89e-05	0.00121	CcSEcCtD
Pralatrexate—Oedema—Docetaxel—lung cancer	3.85e-05	0.0012	CcSEcCtD
Pralatrexate—Pruritus—Gemcitabine—lung cancer	3.84e-05	0.0012	CcSEcCtD
Pralatrexate—Diarrhoea—Irinotecan—lung cancer	3.81e-05	0.00119	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Etoposide—lung cancer	3.79e-05	0.00118	CcSEcCtD
Pralatrexate—Thrombocytopenia—Docetaxel—lung cancer	3.77e-05	0.00118	CcSEcCtD
Pralatrexate—Tachycardia—Docetaxel—lung cancer	3.76e-05	0.00117	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Paclitaxel—lung cancer	3.72e-05	0.00116	CcSEcCtD
Pralatrexate—Diarrhoea—Gemcitabine—lung cancer	3.72e-05	0.00116	CcSEcCtD
Pralatrexate—Anorexia—Docetaxel—lung cancer	3.67e-05	0.00115	CcSEcCtD
Pralatrexate—Body temperature increased—Etoposide—lung cancer	3.67e-05	0.00115	CcSEcCtD
Pralatrexate—Abdominal pain—Etoposide—lung cancer	3.67e-05	0.00115	CcSEcCtD
Pralatrexate—Asthenia—Cisplatin—lung cancer	3.63e-05	0.00113	CcSEcCtD
Pralatrexate—Body temperature increased—Paclitaxel—lung cancer	3.59e-05	0.00112	CcSEcCtD
Pralatrexate—Abdominal pain—Paclitaxel—lung cancer	3.59e-05	0.00112	CcSEcCtD
Pralatrexate—Epistaxis—Doxorubicin—lung cancer	3.56e-05	0.00111	CcSEcCtD
Pralatrexate—Vomiting—Irinotecan—lung cancer	3.54e-05	0.00111	CcSEcCtD
Pralatrexate—Rash—Irinotecan—lung cancer	3.51e-05	0.0011	CcSEcCtD
Pralatrexate—Dermatitis—Irinotecan—lung cancer	3.51e-05	0.0011	CcSEcCtD
Pralatrexate—Diarrhoea—Cisplatin—lung cancer	3.46e-05	0.00108	CcSEcCtD
Pralatrexate—Vomiting—Gemcitabine—lung cancer	3.45e-05	0.00108	CcSEcCtD
Pralatrexate—Dyspnoea—Docetaxel—lung cancer	3.44e-05	0.00107	CcSEcCtD
Pralatrexate—Rash—Gemcitabine—lung cancer	3.42e-05	0.00107	CcSEcCtD
Pralatrexate—Dermatitis—Gemcitabine—lung cancer	3.42e-05	0.00107	CcSEcCtD
Pralatrexate—Decreased appetite—Docetaxel—lung cancer	3.35e-05	0.00105	CcSEcCtD
Pralatrexate—Asthenia—Etoposide—lung cancer	3.33e-05	0.00104	CcSEcCtD
Pralatrexate—Fatigue—Docetaxel—lung cancer	3.32e-05	0.00104	CcSEcCtD
Pralatrexate—Nausea—Irinotecan—lung cancer	3.31e-05	0.00103	CcSEcCtD
Pralatrexate—Constipation—Docetaxel—lung cancer	3.3e-05	0.00103	CcSEcCtD
Pralatrexate—Back pain—Methotrexate—lung cancer	3.29e-05	0.00103	CcSEcCtD
Pralatrexate—Pruritus—Etoposide—lung cancer	3.28e-05	0.00102	CcSEcCtD
Pralatrexate—Asthenia—Paclitaxel—lung cancer	3.26e-05	0.00102	CcSEcCtD
Pralatrexate—Nausea—Gemcitabine—lung cancer	3.23e-05	0.00101	CcSEcCtD
Pralatrexate—Vomiting—Cisplatin—lung cancer	3.22e-05	0.00101	CcSEcCtD
Pralatrexate—Pruritus—Paclitaxel—lung cancer	3.22e-05	0.001	CcSEcCtD
Pralatrexate—Rash—Cisplatin—lung cancer	3.19e-05	0.000997	CcSEcCtD
Pralatrexate—Dermatitis—Cisplatin—lung cancer	3.19e-05	0.000996	CcSEcCtD
Pralatrexate—Diarrhoea—Etoposide—lung cancer	3.17e-05	0.000991	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Docetaxel—lung cancer	3.15e-05	0.000984	CcSEcCtD
Pralatrexate—Anaemia—Methotrexate—lung cancer	3.15e-05	0.000983	CcSEcCtD
Pralatrexate—Diarrhoea—Paclitaxel—lung cancer	3.11e-05	0.000972	CcSEcCtD
Pralatrexate—Abdominal pain—Docetaxel—lung cancer	3.05e-05	0.000952	CcSEcCtD
Pralatrexate—Body temperature increased—Docetaxel—lung cancer	3.05e-05	0.000952	CcSEcCtD
Pralatrexate—Leukopenia—Methotrexate—lung cancer	3.05e-05	0.000952	CcSEcCtD
Pralatrexate—Nausea—Cisplatin—lung cancer	3.01e-05	0.000939	CcSEcCtD
Pralatrexate—Cough—Methotrexate—lung cancer	2.97e-05	0.000928	CcSEcCtD
Pralatrexate—Vomiting—Etoposide—lung cancer	2.95e-05	0.000921	CcSEcCtD
Pralatrexate—Rash—Etoposide—lung cancer	2.92e-05	0.000913	CcSEcCtD
Pralatrexate—Dermatitis—Etoposide—lung cancer	2.92e-05	0.000912	CcSEcCtD
Pralatrexate—Vomiting—Paclitaxel—lung cancer	2.89e-05	0.000903	CcSEcCtD
Pralatrexate—Rash—Paclitaxel—lung cancer	2.87e-05	0.000895	CcSEcCtD
Pralatrexate—Dermatitis—Paclitaxel—lung cancer	2.86e-05	0.000895	CcSEcCtD
Pralatrexate—Back pain—Doxorubicin—lung cancer	2.85e-05	0.00089	CcSEcCtD
Pralatrexate—Asthenia—Docetaxel—lung cancer	2.76e-05	0.000864	CcSEcCtD
Pralatrexate—Nausea—Etoposide—lung cancer	2.75e-05	0.00086	CcSEcCtD
Pralatrexate—Pruritus—Docetaxel—lung cancer	2.73e-05	0.000852	CcSEcCtD
Pralatrexate—Anaemia—Doxorubicin—lung cancer	2.72e-05	0.000851	CcSEcCtD
Pralatrexate—Thrombocytopenia—Methotrexate—lung cancer	2.72e-05	0.00085	CcSEcCtD
Pralatrexate—Nausea—Paclitaxel—lung cancer	2.7e-05	0.000844	CcSEcCtD
Pralatrexate—Anorexia—Methotrexate—lung cancer	2.65e-05	0.000827	CcSEcCtD
Pralatrexate—Leukopenia—Doxorubicin—lung cancer	2.64e-05	0.000824	CcSEcCtD
Pralatrexate—Diarrhoea—Docetaxel—lung cancer	2.64e-05	0.000824	CcSEcCtD
Pralatrexate—TYMS—Azacitidine—Gemcitabine—lung cancer	2.59e-05	0.0239	CbGdCrCtD
Pralatrexate—Cough—Doxorubicin—lung cancer	2.57e-05	0.000803	CcSEcCtD
Pralatrexate—Dyspnoea—Methotrexate—lung cancer	2.48e-05	0.000774	CcSEcCtD
Pralatrexate—Vomiting—Docetaxel—lung cancer	2.45e-05	0.000765	CcSEcCtD
Pralatrexate—Rash—Docetaxel—lung cancer	2.43e-05	0.000759	CcSEcCtD
Pralatrexate—Dermatitis—Docetaxel—lung cancer	2.43e-05	0.000758	CcSEcCtD
Pralatrexate—Decreased appetite—Methotrexate—lung cancer	2.41e-05	0.000754	CcSEcCtD
Pralatrexate—Oedema—Doxorubicin—lung cancer	2.4e-05	0.000751	CcSEcCtD
Pralatrexate—Fatigue—Methotrexate—lung cancer	2.39e-05	0.000748	CcSEcCtD
Pralatrexate—Thrombocytopenia—Doxorubicin—lung cancer	2.35e-05	0.000736	CcSEcCtD
Pralatrexate—Tachycardia—Doxorubicin—lung cancer	2.35e-05	0.000733	CcSEcCtD
Pralatrexate—Methotrexate—ALB—lung cancer	2.33e-05	0.0159	CrCbGaD
Pralatrexate—Anorexia—Doxorubicin—lung cancer	2.29e-05	0.000716	CcSEcCtD
Pralatrexate—Nausea—Docetaxel—lung cancer	2.29e-05	0.000715	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Methotrexate—lung cancer	2.27e-05	0.000709	CcSEcCtD
Pralatrexate—Methotrexate—ABCB1—lung cancer	2.23e-05	0.0152	CrCbGaD
Pralatrexate—Abdominal pain—Methotrexate—lung cancer	2.2e-05	0.000686	CcSEcCtD
Pralatrexate—Body temperature increased—Methotrexate—lung cancer	2.2e-05	0.000686	CcSEcCtD
Pralatrexate—Dyspnoea—Doxorubicin—lung cancer	2.14e-05	0.00067	CcSEcCtD
Pralatrexate—Decreased appetite—Doxorubicin—lung cancer	2.09e-05	0.000653	CcSEcCtD
Pralatrexate—Fatigue—Doxorubicin—lung cancer	2.07e-05	0.000648	CcSEcCtD
Pralatrexate—Constipation—Doxorubicin—lung cancer	2.06e-05	0.000642	CcSEcCtD
Pralatrexate—Asthenia—Methotrexate—lung cancer	1.99e-05	0.000623	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Doxorubicin—lung cancer	1.97e-05	0.000614	CcSEcCtD
Pralatrexate—Pruritus—Methotrexate—lung cancer	1.96e-05	0.000614	CcSEcCtD
Pralatrexate—Body temperature increased—Doxorubicin—lung cancer	1.9e-05	0.000594	CcSEcCtD
Pralatrexate—Abdominal pain—Doxorubicin—lung cancer	1.9e-05	0.000594	CcSEcCtD
Pralatrexate—Diarrhoea—Methotrexate—lung cancer	1.9e-05	0.000594	CcSEcCtD
Pralatrexate—Vomiting—Methotrexate—lung cancer	1.77e-05	0.000552	CcSEcCtD
Pralatrexate—Rash—Methotrexate—lung cancer	1.75e-05	0.000547	CcSEcCtD
Pralatrexate—Dermatitis—Methotrexate—lung cancer	1.75e-05	0.000547	CcSEcCtD
Pralatrexate—Asthenia—Doxorubicin—lung cancer	1.73e-05	0.000539	CcSEcCtD
Pralatrexate—Pruritus—Doxorubicin—lung cancer	1.7e-05	0.000532	CcSEcCtD
Pralatrexate—Nausea—Methotrexate—lung cancer	1.65e-05	0.000515	CcSEcCtD
Pralatrexate—Diarrhoea—Doxorubicin—lung cancer	1.65e-05	0.000514	CcSEcCtD
Pralatrexate—Vomiting—Doxorubicin—lung cancer	1.53e-05	0.000478	CcSEcCtD
Pralatrexate—Rash—Doxorubicin—lung cancer	1.52e-05	0.000474	CcSEcCtD
Pralatrexate—Dermatitis—Doxorubicin—lung cancer	1.51e-05	0.000473	CcSEcCtD
Pralatrexate—Nausea—Doxorubicin—lung cancer	1.43e-05	0.000446	CcSEcCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.34e-05	0.00058	CbGpPWpGaD
Pralatrexate—FPGS—Disease—APC—lung cancer	1.33e-05	0.000576	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KIT—lung cancer	1.33e-05	0.000576	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTA2—lung cancer	1.33e-05	0.000576	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—BIRC5—lung cancer	1.32e-05	0.000574	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—EP300—lung cancer	1.32e-05	0.000573	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PPIA—lung cancer	1.32e-05	0.000571	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGF—lung cancer	1.31e-05	0.000569	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CG—lung cancer	1.31e-05	0.000567	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ALDOA—lung cancer	1.31e-05	0.000566	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.3e-05	0.000565	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—RRM1—lung cancer	1.3e-05	0.000564	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTA3—lung cancer	1.3e-05	0.000564	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—BIRC5—lung cancer	1.29e-05	0.000561	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TERT—lung cancer	1.28e-05	0.000556	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTA1—lung cancer	1.28e-05	0.000555	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCC3—lung cancer	1.27e-05	0.000549	CbGpPWpGaD
Pralatrexate—FPGS—Disease—BRAF—lung cancer	1.25e-05	0.000541	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—POMC—lung cancer	1.24e-05	0.00054	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.23e-05	0.000535	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ADCY1—lung cancer	1.23e-05	0.000535	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6R—lung cancer	1.23e-05	0.000535	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CREBBP—lung cancer	1.23e-05	0.000534	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MDM2—lung cancer	1.23e-05	0.000533	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKR1C1—lung cancer	1.23e-05	0.000532	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—RAF1—lung cancer	1.23e-05	0.000531	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—B4GALT5—lung cancer	1.22e-05	0.00053	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—APOA1—lung cancer	1.22e-05	0.000528	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—CREBBP—lung cancer	1.21e-05	0.000526	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ERBB2—lung cancer	1.21e-05	0.000526	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ENO2—lung cancer	1.21e-05	0.000524	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PPP2R1B—lung cancer	1.2e-05	0.000521	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SMARCA4—lung cancer	1.2e-05	0.000521	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.2e-05	0.00052	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MTOR—lung cancer	1.2e-05	0.000519	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CB—lung cancer	1.2e-05	0.000519	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD4—lung cancer	1.19e-05	0.000518	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—UGT1A1—lung cancer	1.19e-05	0.000516	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTA4—lung cancer	1.19e-05	0.000516	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—lung cancer	1.19e-05	0.000514	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAP2K1—lung cancer	1.17e-05	0.00051	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.17e-05	0.000509	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CD—lung cancer	1.17e-05	0.000506	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTA2—lung cancer	1.16e-05	0.000502	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—BIRC5—lung cancer	1.16e-05	0.000501	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CD—lung cancer	1.15e-05	0.000499	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GNG11—lung cancer	1.15e-05	0.000498	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ALB—lung cancer	1.13e-05	0.000492	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TERT—lung cancer	1.12e-05	0.000486	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTA1—lung cancer	1.12e-05	0.000485	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RB1—lung cancer	1.12e-05	0.000484	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CG—lung cancer	1.11e-05	0.000482	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.11e-05	0.000481	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCC3—lung cancer	1.1e-05	0.000479	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ENO1—lung cancer	1.1e-05	0.000477	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALDOA—lung cancer	1.09e-05	0.000474	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKR1C1—lung cancer	1.07e-05	0.000464	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NCOA3—lung cancer	1.06e-05	0.00046	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—POMC—lung cancer	1.06e-05	0.000459	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MDM2—lung cancer	1.05e-05	0.000453	CbGpPWpGaD
Pralatrexate—FPGS—Disease—RAF1—lung cancer	1.04e-05	0.000452	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—UGT1A1—lung cancer	1.04e-05	0.000451	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1A—lung cancer	1.04e-05	0.000449	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTEN—lung cancer	1.03e-05	0.000448	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCG2—lung cancer	1.03e-05	0.000448	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ADCY1—lung cancer	1.03e-05	0.000448	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CREBBP—lung cancer	1.03e-05	0.000447	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ERBB2—lung cancer	1.03e-05	0.000447	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APP—lung cancer	1.02e-05	0.000443	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.02e-05	0.000441	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTOR—lung cancer	1.02e-05	0.000441	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CB—lung cancer	1.02e-05	0.000441	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD4—lung cancer	1.02e-05	0.00044	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF9—lung cancer	1.01e-05	0.000439	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HPGDS—lung cancer	1.01e-05	0.000439	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ENO2—lung cancer	1.01e-05	0.000439	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—lung cancer	1.01e-05	0.000437	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPP2R1B—lung cancer	1.01e-05	0.000436	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CB—lung cancer	1e-05	0.000435	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GNG11—lung cancer	1e-05	0.000434	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RB1—lung cancer	9.98e-06	0.000433	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—lung cancer	9.93e-06	0.000431	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EP300—lung cancer	9.86e-06	0.000428	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	9.85e-06	0.000427	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTT1—lung cancer	9.82e-06	0.000426	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—lung cancer	9.82e-06	0.000426	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CD—lung cancer	9.77e-06	0.000424	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RB1—lung cancer	9.74e-06	0.000423	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GCLC—lung cancer	9.71e-06	0.000421	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2A6—lung cancer	9.71e-06	0.000421	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JUNB—lung cancer	9.67e-06	0.00042	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—lung cancer	9.65e-06	0.000418	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SRC—lung cancer	9.59e-06	0.000416	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALDOA—lung cancer	9.54e-06	0.000414	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—lung cancer	9.45e-06	0.00041	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOA3—lung cancer	9.26e-06	0.000402	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—STAT3—lung cancer	9.24e-06	0.000401	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NRAS—lung cancer	9.22e-06	0.0004	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ENO1—lung cancer	9.2e-06	0.000399	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ADCY1—lung cancer	9.01e-06	0.000391	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCG2—lung cancer	9.01e-06	0.000391	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HPGDS—lung cancer	8.83e-06	0.000383	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ENO2—lung cancer	8.83e-06	0.000383	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAPK3—lung cancer	8.83e-06	0.000383	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1A—lung cancer	8.81e-06	0.000382	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTEN—lung cancer	8.79e-06	0.000381	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPP2R1B—lung cancer	8.78e-06	0.000381	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—lung cancer	8.78e-06	0.000381	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RB1—lung cancer	8.71e-06	0.000378	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTEN—lung cancer	8.66e-06	0.000375	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—lung cancer	8.65e-06	0.000375	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MYC—lung cancer	8.59e-06	0.000373	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTT1—lung cancer	8.57e-06	0.000372	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—lung cancer	8.56e-06	0.000371	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CB—lung cancer	8.52e-06	0.000369	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MDM2—lung cancer	8.51e-06	0.000369	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FOXO3—lung cancer	8.48e-06	0.000368	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2A6—lung cancer	8.47e-06	0.000367	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GCLC—lung cancer	8.47e-06	0.000367	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—lung cancer	8.44e-06	0.000366	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—lung cancer	8.4e-06	0.000364	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EP300—lung cancer	8.38e-06	0.000364	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	8.31e-06	0.000361	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND1—lung cancer	8.29e-06	0.00036	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—EP300—lung cancer	8.26e-06	0.000358	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2E1—lung cancer	8.25e-06	0.000358	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NQO1—lung cancer	8.16e-06	0.000354	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SRC—lung cancer	8.15e-06	0.000354	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ENO1—lung cancer	8.03e-06	0.000348	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—lung cancer	8.02e-06	0.000348	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—KRAS—lung cancer	7.94e-06	0.000344	CbGpPWpGaD
Pralatrexate—FPGS—Disease—STAT3—lung cancer	7.86e-06	0.000341	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NRAS—lung cancer	7.84e-06	0.00034	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—lung cancer	7.66e-06	0.000332	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—EP300—lung cancer	7.63e-06	0.000331	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HES1—lung cancer	7.51e-06	0.000326	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAPK3—lung cancer	7.51e-06	0.000326	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MDM2—lung cancer	7.43e-06	0.000322	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND1—lung cancer	7.41e-06	0.000322	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTEN—lung cancer	7.36e-06	0.000319	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—STK11—lung cancer	7.36e-06	0.000319	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MYC—lung cancer	7.3e-06	0.000317	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CA—lung cancer	7.29e-06	0.000316	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND1—lung cancer	7.24e-06	0.000314	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2E1—lung cancer	7.2e-06	0.000312	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1A—lung cancer	7.17e-06	0.000311	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—lung cancer	7.14e-06	0.00031	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NQO1—lung cancer	7.12e-06	0.000309	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERCC2—lung cancer	7.02e-06	0.000305	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—EP300—lung cancer	7.02e-06	0.000304	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—lung cancer	7e-06	0.000304	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB3—lung cancer	6.87e-06	0.000298	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MAPK3—lung cancer	6.84e-06	0.000297	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—EP300—lung cancer	6.83e-06	0.000296	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTP1—lung cancer	6.81e-06	0.000295	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KRAS—lung cancer	6.75e-06	0.000293	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HRAS—lung cancer	6.75e-06	0.000293	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—EP300—lung cancer	6.66e-06	0.000289	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYC—lung cancer	6.65e-06	0.000289	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CAT—lung cancer	6.62e-06	0.000287	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TERT—lung cancer	6.58e-06	0.000285	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND1—lung cancer	6.47e-06	0.000281	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—lung cancer	6.46e-06	0.00028	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCB1—lung cancer	6.44e-06	0.000279	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—STK11—lung cancer	6.42e-06	0.000278	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGFR1—lung cancer	6.39e-06	0.000277	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—TYMS—lung cancer	6.33e-06	0.000274	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HIF1A—lung cancer	6.29e-06	0.000273	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1A—lung cancer	6.26e-06	0.000271	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTM1—lung cancer	6.25e-06	0.000271	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CA—lung cancer	6.2e-06	0.000269	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MAPK3—lung cancer	6.12e-06	0.000265	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CA—lung cancer	6.11e-06	0.000265	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APOA1—lung cancer	6.07e-06	0.000263	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MAPK3—lung cancer	5.97e-06	0.000259	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT1—lung cancer	5.96e-06	0.000258	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—EP300—lung cancer	5.96e-06	0.000258	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYC—lung cancer	5.95e-06	0.000258	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTP1—lung cancer	5.94e-06	0.000258	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP1A1—lung cancer	5.93e-06	0.000257	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ERCC2—lung cancer	5.88e-06	0.000255	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYC—lung cancer	5.8e-06	0.000252	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CAT—lung cancer	5.78e-06	0.000251	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HRAS—lung cancer	5.74e-06	0.000249	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCB1—lung cancer	5.62e-06	0.000244	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KIT—lung cancer	5.55e-06	0.000241	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APC—lung cancer	5.55e-06	0.000241	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—lung cancer	5.49e-06	0.000238	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGF—lung cancer	5.48e-06	0.000238	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTM1—lung cancer	5.46e-06	0.000237	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MAPK3—lung cancer	5.34e-06	0.000231	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BRAF—lung cancer	5.21e-06	0.000226	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CA—lung cancer	5.19e-06	0.000225	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYC—lung cancer	5.19e-06	0.000225	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP1A1—lung cancer	5.17e-06	0.000224	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6R—lung cancer	5.15e-06	0.000223	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CREBBP—lung cancer	5.14e-06	0.000223	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ERCC2—lung cancer	5.13e-06	0.000223	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—APOA1—lung cancer	5.09e-06	0.000221	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT1—lung cancer	5.07e-06	0.00022	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKT1—lung cancer	4.99e-06	0.000216	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAP2K1—lung cancer	4.91e-06	0.000213	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—lung cancer	4.88e-06	0.000212	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CD—lung cancer	4.87e-06	0.000211	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CG—lung cancer	4.64e-06	0.000201	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—APOA1—lung cancer	4.44e-06	0.000193	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—POMC—lung cancer	4.42e-06	0.000192	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MDM2—lung cancer	4.37e-06	0.000189	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RAF1—lung cancer	4.35e-06	0.000189	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CREBBP—lung cancer	4.31e-06	0.000187	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB2—lung cancer	4.31e-06	0.000187	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—lung cancer	4.26e-06	0.000185	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTOR—lung cancer	4.25e-06	0.000184	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CB—lung cancer	4.25e-06	0.000184	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKT1—lung cancer	4.24e-06	0.000184	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD4—lung cancer	4.24e-06	0.000184	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—lung cancer	4.21e-06	0.000183	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CD—lung cancer	4.08e-06	0.000177	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CG—lung cancer	4.05e-06	0.000176	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—lung cancer	4.03e-06	0.000175	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—POMC—lung cancer	3.86e-06	0.000167	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CREBBP—lung cancer	3.76e-06	0.000163	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1A—lung cancer	3.68e-06	0.00016	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTEN—lung cancer	3.67e-06	0.000159	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CD—lung cancer	3.56e-06	0.000155	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CB—lung cancer	3.56e-06	0.000154	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—lung cancer	3.53e-06	0.000153	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—lung cancer	3.52e-06	0.000153	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EP300—lung cancer	3.5e-06	0.000152	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SRC—lung cancer	3.4e-06	0.000148	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT3—lung cancer	3.28e-06	0.000142	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NRAS—lung cancer	3.28e-06	0.000142	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAPK3—lung cancer	3.14e-06	0.000136	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CB—lung cancer	3.1e-06	0.000135	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—lung cancer	3.08e-06	0.000133	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTEN—lung cancer	3.07e-06	0.000133	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MYC—lung cancer	3.05e-06	0.000132	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—lung cancer	2.98e-06	0.000129	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—EP300—lung cancer	2.93e-06	0.000127	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KRAS—lung cancer	2.82e-06	0.000122	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTEN—lung cancer	2.68e-06	0.000116	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CA—lung cancer	2.59e-06	0.000112	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—EP300—lung cancer	2.56e-06	0.000111	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HRAS—lung cancer	2.4e-06	0.000104	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—lung cancer	2.29e-06	9.95e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CA—lung cancer	2.17e-06	9.41e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT1—lung cancer	2.12e-06	9.18e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CA—lung cancer	1.89e-06	8.21e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKT1—lung cancer	1.77e-06	7.69e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKT1—lung cancer	1.55e-06	6.71e-05	CbGpPWpGaD
